# Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

> **NCT00463801** · PHASE4 · TERMINATED · sponsor: **Novartis** · enrollment: 52 (actual)

## Conditions studied

- Staphylococcal Skin Infections

## Interventions

- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT00463801
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2007-11
- **Final completion:** —
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** Because of inadequate accrual.
- **Last updated:** 2011-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463801, "Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00463801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*